Online Resources

ASH ISTH NHF WFH 2021 Guidelines on the Diagnosis and Management of VWD

VWD Diagnosis Guidelines VWD Management Guidelines These clinical practice guidelines for the diagnosis and management of von Willebrand disease (VWD) were developed in collaboration with the American Society for Hematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), and National Hemophilia Foundation (NHF) and published in the journal Blood Advances. The two development panels, […]

An international survey to inform priorities for new guidelines on von Willebrand disease

As part of their international collaboration to develop guidelines for the diagnosis and management of von Willebrand disease (VWD), the American Society of Hematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), the National Hemophilia Foundation (NHF) and the World Federation of Hemophilia (WFH), along with the guidelines methods team, conducted a stakeholder survey […]

Evolution of Treatment Products

Adapted from: Global NMO Training 2016 plenary presentation by Glenn Pierce Reviewed by: Glenn Pierce Edited by: Georghia Michael This second module in the Treatment Products eLearning Program explains the evolution of products for the treatment of bleeding disorders, from products derived from blood to artificially produced clotting factor concentrates (CFCs) with extended half-lives (EHL). […]

Updates on Clinical Trials of Gene Therapy in Hemophilia

The fifth and final activity in the Clinical Advances in Gene Therapy for Hemophilia CME curriculum, Updates on Clinical Trials of Gene Therapy in Hemophilia, is a clinical article. Follow Thierry VandenDreissche (Brussels, Belgium) as he takes a deeper dive into the advances made during the recent early phase gene therapy clinical trials in hemophilia […]

Why Gene Therapy for Hemophilia? Exploring the Challenges of Current Therapies

Re-certified for CME credits, to Sept 6, 2020! The fourth activity in the Clinical Advances in Gene Therapy for Hemophilia CME curriculum, Why Gene Therapy for Hemophilia? Exploring the Challenges of Current Therapies, is an expert video exchange on gene therapy in the context of therapies currently available for hemophilia around the world. Watch as […]

The Science of Gene Therapy for Hemophilia

Re-certified for CME credits, to Sept 6, 2020! The third activity in the Clinical Advances in Gene Therapy for Hemophilia CME curriculum, The Science of Gene Therapy for Hemophilia, is an expert video commentary on the vector technology behind gene therapy in hemophilia. Watch as Glenn Pierce, WFH Vice President Medical, examines early clinical trials, […]

Gene Therapy: Past, Present, and Future

The second activity in the Clinical Advances in Gene Therapy for Hemophilia CME curriculum, Gene Therapy: Past, Present, and Future, is a round table video discussion of the evolution of gene therapy in hemophilia. Watch three experts reflect on the development, ongoing research, and current and future uses of gene therapy in hemophilia. A transcript […]

Test Your Knowledge of Gene Therapy in Hemophilia

The first activity in the Clinical Advances in Gene Therapy for Hemophilia CME curriculum, Test Your Knowledge of Gene Therapy in Hemophilia, is an educational self-assessment survey. The questions allow you to see how much you already know about gene therapy in hemophilia and the answers explain the essential information required for a fuller understanding. […]